Quantcast

Comments about ‘$1,000 Sovaldi now hepatitis treatment of choice’

Return to article »

Published: Tuesday, July 29 2014 2:52 p.m. MDT

Comments
  • Oldest first
  • Newest first
  • Most recommended
JKR
Holladay, UT

Gimme a break, Gilead. Pricing this drug like a mortgage is outrageous by any reasonable standard. The underlying problem is that Gilead paid $11 billion dollars for rights to the drug, a foolish amount to pay for any one chemical compound. Insurance companies and many doctors are against it. Shame on Gilead, a company that has done so much for patients with HIV.

cmsense
Kaysville, UT

Pigs get fat but hogs get slaughtered. Gilead is being a hog and this proves that there should be limits to what pharmaceutical are allowed to charge. Republicans complain about the price of Obamacare, but they protect such pricing by pharmaceuticals which shouldn't be allowed. Forcing insurers to cover the insane cost of this medication will add Billions to their premiums which you and me will be paying even though we don't have Hep. C.

to comment

DeseretNews.com encourages a civil dialogue among its readers. We welcome your thoughtful comments.
About comments